GBP5 mouse monoclonal antibody, clone OTI1B2 (formerly 1B2), Biotinylated
| Applications | FC, IF, WB |
| Reactivities | Human |
Products
GBP5 mouse monoclonal antibody, clone OTI5C9 (formerly 5C9), Biotinylated
| Applications | FC, IF, WB |
| Reactivities | Human, Monkey |
GBP5 mouse monoclonal antibody, clone OTI5C9 (formerly 5C9), HRP conjugated
| Applications | FC, IF, WB |
| Reactivities | Human, Monkey |
GBP5 mouse monoclonal antibody, clone OTI1B2 (formerly 1B2), HRP conjugated
| Applications | FC, IF, WB |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) GBP5 mouse monoclonal antibody, clone OTI3G1 (formerly 3G1)
| Applications | FC, WB |
| Reactivities | Human |
GBP5 mouse monoclonal antibody, clone OTI8B12 (formerly 8B12), Biotinylated
| Applications | FC, WB |
| Reactivities | Human |
GBP5 mouse monoclonal antibody, clone OTI8B12 (formerly 8B12), HRP conjugated
| Applications | FC, WB |
| Reactivities | Human |
GBP5 mouse monoclonal antibody, clone OTI8D8 (formerly 8D8), Biotinylated
| Applications | FC, IF, WB |
| Reactivities | Human |
GBP5 mouse monoclonal antibody, clone OTI4D9 (formerly 4D9), Biotinylated
| Applications | FC, IF, WB |
| Reactivities | Human |
GBP5 mouse monoclonal antibody, clone OTI8D8 (formerly 8D8), HRP conjugated
| Applications | FC, IF, WB |
| Reactivities | Human |
GBP5 mouse monoclonal antibody, clone OTI4D9 (formerly 4D9), HRP conjugated
| Applications | FC, IF, WB |
| Reactivities | Human |
GBP5 mouse monoclonal antibody, clone OTI3G1 (formerly 3G1), Biotinylated
| Applications | FC, WB |
| Reactivities | Human |
GBP5 mouse monoclonal antibody, clone OTI3G1 (formerly 3G1), HRP conjugated
| Applications | FC, WB |
| Reactivities | Human |
GBP5 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector, 5µg of each construct provided
| Format | Retroviral plasmids |
| Vector | pGFP-V-RS |
Gbp5 (Mouse) - 3 unique 27mer siRNA duplexes - 2 nmol each
| Purity | HPLC purified |
| Number of Transfections | Approximately 330 transfections/2nmol in 24-well plate under optimized conditions (final conc. 10 nM). |
